drugset / Press release
Emergent BioSolutions Completes Acquisition of Raxibacumab, an FDA-Approved Anthrax Monoclonal Antibody, From GSK
2017-10-03 · Emergent BioSolutions · original emergentbiosolutions.com ↗
100317 - EBS Completes Acquisition of Raxibacumab FINAL.pdf 137.9 KB
The release as fetched from its publisher. emergentbiosolutions.com ↗